2,573
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Assessment of solid microneedle rollers to enhance transmembrane delivery of doxycycline and inhibition of MMP activity

, &
Pages 942-951 | Received 13 Apr 2017, Accepted 22 May 2017, Published online: 15 Jun 2017

References

  • Badran MM, Kuntsche J, Fahr A. (2009). Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation. Eur J Pharm Sci 36:511–23.
  • Bal SM, Caussin J, Pavel S, et al. (2008). In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 35:193–202.
  • Benson H. (2005). Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv 2:23–33.
  • Bildt MM, Bloemen M, Kuijupers-Jagtman MA et al. (2009). Matrix metalloproteinase inhibitors reduce collagen gel contraction and alpha-smooth muscle actin expression by periodontal ligament cells. J Periodontal Res 44:266–74.
  • Chernokalskaya E, Vivek J, Kavonian M, et al. (2014). Polymeric membranes with human skin-like permeability properties and uses thereof. US Patent 8765254.
  • Edens C, Collins ML, Ayers J, et al. (2013). Measles vaccination using a microneedle patch. Vaccine 31:3403–9.
  • Franco C, Ho B, Mulholland D, et al. (2006). Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices. Am J Pathol 168:1697–709.
  • Gupta J, Felner EI, Prausnitz MR. (2009). Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther 11:329–37.
  • Gupta J, Park SS, Bondy B, et al. (2011). Infusion pressure and pain during microneedle injection into skin of human subjects. Biomaterials 32:6823–31.
  • Jj N, Na R, Faster FEI, et al. (2013). Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes. ESA 14:459–65.
  • Kaushik S, Hord a. H, Denson DD, et al. (2001). Lack of pain associated with microfabricated microneedles. Anesth Analg 92:502–4.
  • Kim HM, Lim YY, An JH, et al. (2012). Transdermal drug delivery using disk microneedle rollers in a hairless rat model. Int J Dermatol 51:859–63.
  • Kim M, Jung B, Park H. (2012). Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. Biomaterials 33:668–78.
  • Kogawa AC, Salgado HRN. (2012). Doxycycline hyclate: a review of properties, applications and analytical methods. Int J Life Sci Pharma Res 2:11–25.
  • Kommareddy S, Baudner BC, Oh S, et al. (2012). Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci 101:1021–7.
  • Li H, Ezra DG, Burton MJ, et al. (2013). Doxycycline prevents matrix remodeling and contraction by trichiasis-derived conjunctival fibroblasts. Invest Ophthalmol Vis Sci 54:4675–82.
  • Li H, Roos JCP, Rose GE, et al. (2015). Eyelid and sternum fibroblasts differ in their contraction potential and responses to inflammatory cytokines. Plast Reconstr Surg Glob Open 3:e448.
  • Liebl H, Kloth C. (2012). Skin cell proliferation stimulated by microneedles. J Am Coll Clin Wound Spec 4:2–6.
  • Manning MW, Cassis LA, Daugherty A. (2003). Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 23:483–8.
  • Markov I. (2003). Fundamentals of nucleation, crystal growth and epitaxy. 2nd ed. London, UK: World Scientific Publishing.
  • Moor AN, Vachon DJ, Gould LJ. (2009). Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers. Wound Repair Regen 17:832–9.
  • Naidoo C, Gould A, Peters J, et al. (2009). Matrix metalloproteinases inhibition and antibiotics in the treatment of chronic wounds. Wound Heal South Africa 2:71–3.
  • Nava-Arzaluz MG, Calderon-Lojero I, Quintanar-Guerrero D, et al. (2012). Microneedles as transdermal delivery systems: combination with other enhancing strategies. Curr Drug Deliv 9:57–73.
  • Nwomeh BC, Liang H, Cohen IK, et al. (1999). MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 195:189–95.
  • Park J, Choi S, Seo S, et al. (2010). A microneedle roller for transdermal drug delivery. Eur J Pharm Biopharm 76:282–9.
  • Pathan IB, Setty CM. (2009). Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res 8:173–9.
  • Saarialho-Kere UK. (1998). Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers. Arch Dermatol Res 290:S47–S54.
  • Sloan B, Scheinfeld N. (2008). The use and safety of doxycycline hyclate and other second-generation tetracyclines. Expert Opin Drug Saf 7:571–7.
  • Stechmiller J, Cowan L, Schultz G. (2010). The role of doxycycline as a matrix metalloproteinase inhibitor for the treatment of chronic wounds. Biol Res Nurs 11:336–44.
  • Trengove NJ, Stacey MC, Macauley S, et al. (1999). Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7:442–52.
  • Trommer H, Neubert RHH. (2006). Overcoming the stratum corneum: the modulation of skin penetration. A review. Skin Pharmacol Physiol 19:106–21.
  • Uchida T, Kadhum WR, Kanai S, et al. (2015). Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M™. Eur J Pharm Sci. 67:113–8.
  • van der Maaden K, Jiskoot W, Bouwstra J. (2012). Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release 161:645–55.
  • Vandervoort J, Ludwig A. (2008). Microneedles for transdermal drug delivery: a minireview. Front Biosci 13:1711–5.
  • Vrdoljak A, McGrath MG, Carey JB, et al. (2012). Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release 159:34–42.
  • Widgerow AD. (2011). Chronic wound fluid-thinking outside the box. Wound Repair Regen 19:287–91.
  • Williams AC, Barry BW. (2004). Penetration enhancers. Adv Drug Deliv Rev 56:603–18.
  • Wu Y, Qiu Y, Zhang S, et al. (2008). Microneedle-based drug delivery: studies on delivery parameters and biocompatibility. Biomed Microdevices 10:601–10.
  • Wysoci A, Stiano-Coico L, Grinnell F. (1993). Wound fluid from chronic leg ulcers contain elevated levels of MMP-2 and MMP-9. J Invest Dermatol 101:64–8.
  • Ya-Xian Z, Suetake T, Tagami H. (1999). Number of cell layers of the stratum corneum in normal skin – relationship to the anatomical location on the body, age, sex and physical parameters. Arch Dermatol Res 291:555–9.
  • Yager DR, Nwomeh BC. (1999). The proteolytic environment of chronic wounds. Wound Repair Regen 7:433–41.
  • You SK, Noh YW, Park HH, et al. (2010). Effect of applying modes of the polymer microneedle-roller on the permeation of L-ascorbic acid in rats. J Drug Target 18:15–20.
  • Zhou C, Liu Y, Wang H, et al. (2010). Transdermal delivery of insulin using microneedle rollers in vivo. Int J Pharm 392:127–33.